Download PDF
1 / Pages

Other users also viewed these articles

Bisphenol A in renal insufficiency: how long will it be used? Is it time to avoid it? Emilio González-Parra; Rafael Moreno-Gómez-Toledano; Sebastián Mas-Fontao; Ricardo J. Bosch;
Nefrologia (English Version). 2024;44:313-6
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapy Marian Goicoechea; Francisco Gomez-Preciado; Silvia Benito; Joan Torras; Roser Torra; Ana Huerta; Alejandra Restrepo; Jessica Ugalde; Daniela Estefania Astudillo; Irene Agraz; Manuel Lopez-Mendoza; Gabriel de Arriba; Elena Corchete; Borja Quiroga; Maria Jose Gutierrez; Maria Luisa Martin-Conde; Vanessa Lopes; Carmela Ramos; Irene Mendez; Mercedes Cao; Fernando Dominguez; Alberto Ortiz;
Nefrologia (English Version). 2021;41:652-60
Toward optimization and excellence via a multidisciplinary care model for patients with chronic kidney disease in Spain: The CARABELA-CKD initiative Borja Quiroga; Juan José Gorgojo; Jesús Ignacio Diago; Pedro Ruiz;
Nefrologia (English Version). 2024;44:912-5